Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R24HL123767, HL060056)
National Center for Advancing Translational Sciences (TR001082)
National Institutes of Health (R01GM120609)
Jayden de Luca Foundation
Cardiovascular Medical Research and Education Fund
Text and Data Mining valid from 2018-07-20
Received: 29 January 2018
Accepted: 9 July 2018
First Online: 20 July 2018
Ethics approval and consent to participate
: Written informed consent (and assent when appropriate) was obtained from patients or parents/legal guardians under a protocol approved by the Institutional Review Board at Columbia University Medical Center or Children’s Hospital of Colorado. The research complied with the principles of the Declaration of Helsinki.
: Written informed consent for publication was obtained at enrollment.
: CG-J, AKK, JGR, JDO, AB, and FD are full time employees of Regeneron Pharmaceuticals Inc. and receive stock options as part of compensation. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.